Tailor-Made: Individualizing Type 2 Diabetes Management with GLP-1 Receptor Agonists

Share

Program Content

Activities

  • Understanding GLP-1 RAs: Why They Are an Effective Option in Managing Patients With Type 2 Diabetes
    Understanding GLP-1 RAs: Why They Are an Effective Option in Managing Patients With Type 2 Diabetes
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 15, 2022

    Expires: February 14, 2023

    View Activity
  • Tailor-Made: Individualizing Type 2 Diabetes Management with GLP-1 Receptor Agonists
    Tailor-Made: Individualizing Type 2 Diabetes Management with GLP-1 Receptor Agonists
    Virtual Lecture
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 15, 2022

    Expires: July 14, 2023

    View Activity

Faculty

cover img faculity

Maria Argoud, PA-C

Physician Assistant
San Diego Coastal Endocrinology
San Diego, California

cover img faculity

Darren K. McGuire, MD, MHSc, FACC

Distinguished Teaching Professor of Medicine
Jere H. Mitchell, MD Distinguished Chair in Cardiovascular Science
Division of Cardiology, Department of Medicine
University of Texas Southwestern Medical Center
Dallas, Texas

cover img faculity

Richard E. Pratley, MD

Samuel E. Crockett Chair in Diabetes Research
Medical Director
AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead
AdventHealth Translational Research Institute
Adjunct Professor of Medicine
Johns Hopkins University School of Medicine
Orlando, Florida

cover img faculity

Laura Ross, PA-C, CLS, AACC, DipACLM

Physician Assistant
Department of Cardiology
Park Nicollet Heart and Vascular Center Methodist Hospital
St. Louis Park, Minnesota

Provided by

ProCE Banner

Supporters

Novo Nordisk